Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker's research into nanotechnology.
China-based antibacterial technology developer Jinda Nano Tech secured approximately RMB200m ($29.1m) on Friday in a series B round featuring supply chain services provider Xiamen C&D, China Money Network reported.
The round was led by venture capital firm Shunwei Capital, which disclosed the news on its WeChat account, and included participation from investment manager Blueprint Innovation.
Founded in 2006, Jinda designs and manufacturers antibacterial materials that are used for the production of textiles, shoe materials, medical products, building materials and plastics.
…
